跳至主要内容
临床试验/NCT06277206
NCT06277206已完成不适用

A Study Using 18F-FAPI PET to Evaluate Pathologic Response to Systemic Treatment in Pancreatic Adenocarcinoma

Zhejiang University1 个研究点 分布在 1 个国家目标入组 59 人开始时间: 2021年8月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
59
试验地点
1
主要终点
Change of Mean standardized uptake value

研究概览

简要总结

To explore the potential utility of 18F-FAPI-04 PET/CT for pathologic response evaluation to systemic treatment in PDAC

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • suspected to have pancreatic cancer by radiological imaging
  • planned systemic treatment
  • possibility of conversion surgery
  • willingness to participate the study

排除标准

  • without pathologically confirmed pancreatic cancer
  • poor performance status or organ functions that cannot meet the systemic treatment requirements
  • metastatic disease
  • pregnant patients

结局指标

主要结局

Change of Mean standardized uptake value

时间窗: Baseline and preoperation

Change of SUVmean before and after treatment

Change of Maximum standardized uptake value

时间窗: Baseline and preoperation

Change of SUVmax before and after treatment

次要结局

  • Mean standardized uptake value(Baseline)
  • Change of Total Lesion FAP expression(Baseline and preoperation)
  • Maximum standardized uptake value(Baseline)
  • Metabolic Tumor Volume(Baseline)
  • Change of Metabolic Tumor Volume(Baseline and preoperation)
  • Total Lesion FAP expression(Baseline)

研究者

发起方
Zhejiang University
申办方类型
Other
责任方
Principal Investigator
主要研究者

TingBo Liang

Professor

Zhejiang University

研究点 (1)

Loading locations...

相似试验